Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.
Authors:
- 15 November 1993
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (22) , 10764-10768
Abstract
Gene therapy offers a radical different approach to the treatment of arthritis. Here we have demonstrated that two marker genes (lacZ and neo) and cDNA coding for a potentially therapeutic protein (human interleukin 1-receptor-antagonist protein; IRAP or IL-1ra) can be delivered, by ex vivo techniques, to the synovial lining of joints; intraarticular expression of IRAP inhibited intraarticular responses to interleukin 1. To achieve this, lapine synoviocytes were first transduced in culture by retroviral infection. The genetically modified synovial cells were then transplanted by intraarticular injection into the knee joints of rabbits, where they efficiently colonized the synovium. Assay of joint lavages confirmed the in vivo expression of biologically active human IRAP. With allografted cells, IRAP expression was lost by 12 days after transfer. In contrast, autografted synoviocytes continued to express IRAP for approximately 5 weeks. Knee joints expressing human IRAP were protected from the leukocytosis that otherwise follows the intraarticular injection of recombinant human interleukin 1 beta. Thus, we report the intraarticular expression and activity of a potentially therapeutic protein by gene-transfer technology; these experiments demonstrate the feasibility of treating arthritis and other joint disorders with gene therapy.Keywords
This publication has 24 references indexed in Scilit:
- The synovial activation of chondrocytes: evidence for complex cytokine interactions involving a possible novel factorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonistCytokine, 1991
- Synovial fluid concentration of five different cytokines in rheumatic diseases.Annals of the Rheumatic Diseases, 1990
- Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- In vivo studies on the effects of human recombinant interleukin-1β on articular cartilageInflammation Research, 1989
- HIG-82: An established cell line from rabbit periarticular soft tissue, which retains the “activatable” phenotypeIn Vitro Cellular & Developmental Biology, 1988
- Characterisation of chondrocyte activation in response to cytokines synthesised by a synovial cell lineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- A controlled study of ana+ rf‐ arthritisArthritis & Rheumatism, 1978